Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

IMPAKT 2012 Banner

Interview with Prof Reis-Filho on molecular pathology at the basis of personalised medicine

Prof Reis-Filho explores the latest high throughput technology results in molecular pathology to improve treatment for cancer patients. 

Interview with Dr Angelo Di Leo on potential new promising approaches to attack the different subtypes of triple negative breast cancer

Dr Di Leo explains why triple negative breast cancer is a difficult heterogeneous disease and which are potential new promising approaches.

Interview with Prof Swanton on the challenges posed by intratumor heterogeneity

Prof Swanton offers a clear-cut picture of challeges and opportunities offered by improved knowledge of intratumor heterogeneity.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.